Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
Clinical trial NCT05551208 · RECRUITING
Trial details
- NCT number
- NCT05551208
- Sponsor
- Chongqing University Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2024-08-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.